Document is current
Any future updates will be listed below
-
Authors
Terveen, Daniel C.
Sarkisian, Steven R. Jr
Vold, Steven D.
Selvadurai, Deepan
Williamson, Blake K.
Ristvedt, Deborah G.
Bleeker, Adam R.
Dhamdhere, Kavita
Dickerson, Jaime E. Jr
- License Information
-
More Information
Article History
Received: 25 May 2022
Accepted: 7 October 2022
First Online: 13 October 2022
Declarations
:
: Dr. Terveen has received a research grant from Sight Sciences, Drs. Ristvedt, Sarkisian, Vold, and Williamson are consultants and speakers for Sight Sciences and Glaukos. Dr. Sarkisian has an equity interest in Sight Sciences. Drs. Dickerson and Dhamdhere are employees of Sight Sciences, Inc. The other authors have no financial interest.
: The study was reviewed by the Institutional Review Board (WCG IRB, Puyallup, WA, USA; IRB Protocol No: 20213289). All patient data was treated with confidentiality, in accordance with the Declaration of Helsinki. This study is not considered an “Applicable Clinical Trial” under 42 CFR 11.22(b) and is exempt from listing on clinicaltrials.gov.
: Waiver of consent was granted by the WCG IRB due to the retrospective non-interventional nature of the study.
